These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Production of tumor necrosis factor/cachectin by human T cell lines and peripheral blood T lymphocytes stimulated by phorbol myristate acetate and anti-CD3 antibody. Sung SS, Bjorndahl JM, Wang CY, Kao HT, Fu SM. J Exp Med; 1988 Mar 01; 167(3):937-53. PubMed ID: 2965212 [Abstract] [Full Text] [Related]
4. Phorbol myristate acetate induction of lymphotoxins from continuous human B lymphoid cell lines in vitro. Yamamoto RS, Johnson DL, Masunaka IK, Granger GA. J Biol Response Mod; 1984 Mar 01; 3(1):76-87. PubMed ID: 6608577 [Abstract] [Full Text] [Related]
7. Expression of surface lymphotoxin and tumor necrosis factor on activated T, B, and natural killer cells. Ware CF, Crowe PD, Grayson MH, Androlewicz MJ, Browning JL. J Immunol; 1992 Dec 15; 149(12):3881-8. PubMed ID: 1281193 [Abstract] [Full Text] [Related]
8. Regulation of lymphotoxin-beta by tumor necrosis factor, phorbol myristate acetate, and ionomycin in Jurkat T cells. Voon DC, Subrata LS, Abraham LJ. J Interferon Cytokine Res; 2001 Nov 15; 21(11):921-30. PubMed ID: 11747624 [Abstract] [Full Text] [Related]
9. Human T cell activation: differential response to anti-CD28 as compared to anti-CD3 monoclonal antibodies. Bjorndahl JM, Sung SS, Hansen JA, Fu SM. Eur J Immunol; 1989 May 15; 19(5):881-7. PubMed ID: 2544432 [Abstract] [Full Text] [Related]
10. Production of lymphotoxin and tumour necrosis factor by a T-cell hybridoma. Kobayashi Y, Asada M, Osawa T. Immunology; 1987 Feb 15; 60(2):213-7. PubMed ID: 3102354 [Abstract] [Full Text] [Related]
11. Lymphotoxin produced by human B- and T-cell lines appears in two distinct forms. Lantz M, Lindvall L, Pantazis P, Olsson I. Mol Immunol; 1991 Feb 15; 28(1-2):9-16. PubMed ID: 2011132 [Abstract] [Full Text] [Related]
13. Differential regulation of lymphotoxin and tumor necrosis factor genes in human T lymphocytes. English BK, Weaver WM, Wilson CB. J Biol Chem; 1991 Apr 15; 266(11):7108-13. PubMed ID: 1707879 [Abstract] [Full Text] [Related]
15. Human T-cell hybridomas producing lymphokines. II. Enhancement of lymphotoxin secretion from human T-cell hybridomas by phorbol myristate acetate. Asada M, Higuchi M, Kobayashi Y, Osawa T. Cell Immunol; 1983 Apr 01; 77(1):150-60. PubMed ID: 6340837 [Abstract] [Full Text] [Related]
16. Functional analysis of the lymphotoxin-beta promoter. Sequence requirements for PMA activation. Kuprash DV, Osipovich OA, Pokholok DK, Alimzhanov MB, Biragyn A, Turetskaya RL, Nedospasov SA. J Immunol; 1996 Apr 01; 156(7):2465-72. PubMed ID: 8786306 [Abstract] [Full Text] [Related]
17. Human T cell hybridomas producing cytotoxic lymphokines: induction of lymphotoxin release and killer cell activity by anti-CD3 monoclonal antibody or lectins and phorbol ester. Ware CF, Green LM, Reade J, Stern ML, Berger AE. Lymphokine Res; 1986 Apr 01; 5(4):313-24. PubMed ID: 2878123 [Abstract] [Full Text] [Related]
18. Superoxide-dependent nitroblue tetrazolium reduction and expression of cytochrome b-245 components by human tonsillar B lymphocytes and B cell lines. Maly FE, Nakamura M, Gauchat JF, Urwyler A, Walker C, Dahinden CA, Cross AR, Jones OT, de Weck AL. J Immunol; 1989 Feb 15; 142(4):1260-7. PubMed ID: 2536769 [Abstract] [Full Text] [Related]
19. Production of tumor necrosis factor (TNF-alpha) and lymphotoxin (TNF-beta) by murine pre-B and B cell lymphomas. Laskov R, Lancz G, Ruddle NH, McGrath KM, Specter S, Klein T, Djeu JY, Friedman H. J Immunol; 1990 May 01; 144(9):3424-30. PubMed ID: 2329277 [Abstract] [Full Text] [Related]